Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Original Article

  • Open Access
    Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
    Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma and Zhiming Shao
    Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0492
  • Open Access
    Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
    Shuangcheng Li, Tianci Wang, Xinghui Xiao, Xiaodong Zheng, Haoyu Sun, Rui Sun, Hongdi Ma, Zhigang Tian and Xiaohu Zheng
    Cancer Biology & Medicine April 2024, 21 (4) 331-346; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0341
  • Open Access
    Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China
    Jian Chen, Zhe Yang, Fengqiang Gao, Zhisheng Zhou, Junli Chen, Di Lu, Kai Wang, Meihua Sui, Zhengxin Wang, Wenzhi Guo, Guoyue Lyu, Haizhi Qi, Jinzhen Cai, Jiayin Yang, Shusen Zheng and Xiao Xu
    Cancer Biology & Medicine April 2024, 21 (4) 347-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0453
  • Open Access
    DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
    Junya Yan, Shibo Wang, Jing Zhang, Qiangqiang Yuan, Xianchun Gao, Nannan Zhang, Yan Pan, Haohao Zhang, Kun Liu, Jun Yu, Linbin Lu, Hui Liu, Xiaoliang Gao, Sheng Zhao, Wenyao Zhang, Abudurousuli Reyila, Yu Qi, Qiujin Zhang, Shundong Cang, Yuanyuan Lu, Yanglin Pan, Yan Kong and Yongzhan Nie
    Cancer Biology & Medicine March 2024, 21 (3) 252-266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0303
  • Open Access
    Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression
    Lulu Han, Yuxin Chen, Nan Huang, Xiaowan Zhou, Yanfang Lv, Huizhong Li, Dafei Chai, Junnian Zheng and Gang Wang
    Cancer Biology & Medicine February 2024, 21 (2) 175-192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0248
  • Open Access
    Large-scale loss-of-function perturbations reveal a comprehensive epigenetic regulatory network in breast cancer
    Yumei Wang, Haiyan Wang, Wei Shao, Yuhui Chen, Yu Gui, Chao Hu, Xiaohong Yi, Lijun Huang, Shasha Li and Dong Wang
    Cancer Biology & Medicine January 2024, 21 (1) 83-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0276
  • You have access
    Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
    Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li and Dingwei Ye
    Cancer Biology & Medicine December 2023, 20 (12) 1047-1059; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0335
  • You have access
    TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors
    Xiangxiang Gu, Yipan Zhu, Cancan Zhao, Yixin Cao, Jingying Wang, Qiangzhe Zhang and Luyuan Li
    Cancer Biology & Medicine November 2023, 20 (11) 869-884; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0245
  • You have access
    Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma
    Zhou Zhu, Hui Tang, Jinrong Ying, Yuejuan Cheng, Xiang Wang, Yingyi Wang and Chunmei Bai
    Cancer Biology & Medicine October 2023, 20 (10) 765-778; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0189
  • You have access
    Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
    Xiaoying Zhao, Zhiyu Chen, Xiaowei Zhang, Xiaodong Zhu, Wen Zhang, Lixin Qiu, Chenchen Wang, Mingzhu Huang, Zhe Zhang, Wenhua Li, Lei Yang and Weijian Guo
    Cancer Biology & Medicine September 2023, 20 (9) 682-688; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0112

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 45

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire